Schini V B, Katusic Z S, Vanhoutte P M
Center for Experimental Therapeutics, Baylor College of Medicine, Houston, Texas.
J Pharmacol Exp Ther. 1990 Dec;255(3):994-1000.
The response to small peptides such as Arg-vasopressin, oxytocin and tachykinins was investigated in cultured porcine aortic endothelial cells. The production of endothelium-derived nitric oxide was assessed indirectly by the accumulation of cyclic GMP, a response that is due to the increased activity of soluble guanylate cyclase of the endothelial cells after release of the mediator. Arg-vasopressin, oxytocin, substance P and physalae-min (an analog of substance P, pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2) markedly and transiently stimulated the production of cyclic GMP without affecting that of cyclic AMP. Treatment of endothelial cells with either hemoglobin or methylene blue reduced significantly both the basal and stimulated level of cyclic GMP. The production of cyclic GMP evoked by Arg-vasopressin and substance P was inhibited selectively by NG-monomethyl-L-arginine but not by its D-enantiomer. The neurohypophyseal hormones and related peptides stimulated the accumulation of cyclic GMP in a concentration-dependent manner, with the following relative order of potency: oxytocin greater than Lys-vasopressin greater than Arg-vasopressin much greater than [deamino-Cys1, D-Arg8]-vasopressin. The production of cyclic GMP evoked by oxytocin was inhibited selectively by [d(CH2)5, Tyr(OMe)2, Orn8]-vasotocin, an oxytocin antagonist. The production of cyclic GMP evoked by Arg-vasopressin and Lys-vasopressin was inhibited by [beta-mercapto-beta, beta-cyclopentamethylene-propionyl1, O-Me-Tyr2, Arg8]-vasopressin, a selective V1-receptor antagonist. The moderate production of cyclic GMP evoked by [deamino-Cys1, D-Arg8]-vasopressin was inhibited significantly by the V1-receptor antagonist. The peptide antagonists affected only minimally or not at all the production of cyclic GMP evoked by a donor of nitric oxide, SIN-1 (3-Morpholino-Sydnonimine). These observations indicate that 1) neurohypophyseal hormones and tachykinins stimulate the accumulation of cyclic GMP in cultured porcine aortic endothelial cells by increasing the production of endothelial-derived nitric oxide, which in turn enhances the activity of soluble guanylate cyclase; 2) the production of cyclic GMP in response to oxytocin is due to activation of oxytocinergic receptors; and 3) the production of cyclic GMP evoked by Arg-vasopressin and Lys-vasopressin is due mostly to activation of V1-vasopressinergic receptors.
在培养的猪主动脉内皮细胞中研究了对诸如精氨酸加压素、催产素和速激肽等小肽的反应。通过环鸟苷酸(cGMP)的积累间接评估内皮源性一氧化氮的产生,这种反应是由于介质释放后内皮细胞可溶性鸟苷酸环化酶活性增加所致。精氨酸加压素、催产素、P物质和physalaemin(P物质类似物,pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2)显著且短暂地刺激了cGMP的产生,而不影响环腺苷酸(cAMP)的产生。用血红蛋白或亚甲蓝处理内皮细胞可显著降低cGMP的基础水平和刺激水平。精氨酸加压素和P物质引起的cGMP产生被NG-单甲基-L-精氨酸选择性抑制,而其D-对映体则无此作用。神经垂体激素和相关肽以浓度依赖性方式刺激cGMP的积累,其效力的相对顺序如下:催产素大于赖氨酸加压素大于精氨酸加压素远大于[脱氨基-Cys1,D-Arg8]-加压素。催产素引起的cGMP产生被催产素拮抗剂[d(CH2)5,Tyr(OMe)2,Orn8]-缩宫素选择性抑制。精氨酸加压素和赖氨酸加压素引起的cGMP产生被选择性V1-加压素能受体拮抗剂[β-巯基-β,β-环亚戊基丙酰1,O-甲基-Tyr2,Arg8]-加压素抑制。[脱氨基-Cys1,D-Arg8]-加压素引起的cGMP适度产生被V1-受体拮抗剂显著抑制。肽拮抗剂对一氧化氮供体SIN-1(3-吗啉代-西多硝胺)引起的cGMP产生影响极小或无影响作用。这些观察结果表明:1)神经垂体激素和速激肽通过增加内皮源性一氧化氮的产生来刺激培养的猪主动脉内皮细胞中cGMP的积累,进而增强可溶性鸟苷酸环化酶的活性;2)对催产素反应产生的cGMP是由于催产素能受体的激活;3)精氨酸加压素和赖氨酸加压素引起的cGMP产生主要是由于V1-加压素能受体的激活。